Cancer Biology & Medicine (Mar 2024)

Peptide drugs: a new direction in cancer immunotherapy

Xinghua Sui,
Xiaoshuang Niu,
Xiuman Zhou,
Yanfeng Gao

Affiliations

Xinghua Sui: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China
Xiaoshuang Niu: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China
Xiuman Zhou: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China
Yanfeng Gao: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China

DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0297
Journal volume & issue: Vol. 21, no. 3
pp. 198 – 203

Abstract

No abstracts available.

Published in Cancer Biology & Medicine

ISSN: 2095-3941 (Print)
Publisher: China Anti-Cancer Association
Country of publisher: China
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.cancerbiomed.org/

About the journal